The newly released 2011 DIR Annual Report reviews the latest basic, clinical, and translational research being pursued by the staff scientists within DIR at the NICHD. Contributing to this effort are 79 tenured and tenure-track investigators and approximately 1,200 administrative and research staff. In 2011, DIR project areas ranged from vaccine development to genomics, from reproduction to regenerative medicine, and from the neurosciences and early human development to biophysics and imaging.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Researchers Identify Protein Essential for Embryo Implantation
Researchers funded by the National Institutes of Health have identified a key step in the establishment of a pregnancy. Their discovery shows how the hormone progesterone suppresses the growth of the uterus's lining so that a fertilized egg can implant in the uterus.
NICHD Director’s Lecture Series: New Frontiers in Endometriosis
NICHD Director Alan E. Guttmacher, M.D., initiated the NICHD Director’s Lecture Series as a way to showcase cutting-edge science relevant to the Institute’s mission. The forum also enables staff and other attendees to interact with other nationally recognized scientists.
New Intramural Report Available
The Division’s research programs address topics ranging from molecular and cellular biology, genetics, and endocrine and genetic disorders, to physical biology, neurosciences, immunology, reproduction, and behavioral research. Its projects are organized around the theme of the orchestration of life by molecular messengers.
Hormonal Contraception Does Not Appear to Increase HIV Risk
Using hormonal contraception does not appear to increase women's overall risk of infection with the AIDS virus, report the authors of a large study commissioned by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.
Bone Density Appears to Recover After Adolescents Discontinue Injected Contraceptive
Lower bone density appears to recover in adolescent females once they stop using the injected contraceptive depot medroxyprogesterone acetate (DMPA), according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.
Enzyme Essential To Sperm Movement Provides Target for New Contraceptive Approach
A team of researchers has determined that an enzyme in sperm is necessary for sperm movement. Mice bred to lack this enzyme produce sperm that cannot swim toward egg cells to fertilize them.
Depo Provera Appears to Increase Risk for Chlamydial & Gonococcal Infections
The injectable contraceptive depot-medroxyprogesterone acetate (DMPA) appears to increase a woman's risk of acquiring the sexually transmitted infections chlamydia and gonorrhea by approximately three fold when compared to women not using a hormonal contraceptive, according to a study jointly funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health and the U.S. Agency for International Development's Office of Population and Reproductive Health.
Bone Loss in Depo-Provera Users Largely Reversible
A new study confirms earlier reports that Depo-Provera, an injectable contraceptive popular among young and low-income American women, is strongly associated with bone density loss.
NICHD Study Finds No Association Between Oral Contraceptive Use & Breast Cancer For Women from 35 to 64
Women between the ages of 35 and 64 who took oral contraceptives at some point in their lives are no more likely to develop breast cancer than are other women the same age, according to findings from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Women's Contraceptive and Reproductive Experiences Study (Women's CARE).
Few Women Regret Sterilization Procedures
Few of the women who undergo tubal sterilization or whose husbands undergo vasectomy later go on to regret either procedure, according to a study funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and conducted by the Centers for Disease Control and Prevention (CDC).
Federal Funds Support Expansion of Research in Women's Health
In a major new effort to stimulate women's health research across a variety of disciplines, the National Institutes of Health announced it will fund 11 awards to support development of new research in women's health.
NICHD Study Shows Treatment Fails to Prevent Preterm birth
In the largest study of its kind, antibiotic treatment to eliminate bacterial vaginosis failed to prevent premature birth, according to a study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and coauthored by researchers at the NICHD and several other institutions.
NIH Awards Additional Funding for New Researchers in Women's Reproductive Health
The National Institutes of Health (NIH) has awarded $3.2 million to fund centers that will support early research careers in the field of obstetrics and gynecology.
Four Million Dollars Awarded for New Researchers in Women’s Health
To help advance research in women's reproductive health, twelve centers have been awarded a total of $4 million to support early research careers in the field of obstetrics and gynecology.